SINGAPORE - An injectable drug used to treat obesity is now available via prescription from any licensed physician in ...

Dr Rowan French insists lasting weight loss can only be achieved through a balanced approach to psychology, exercise and ...

Debilitating headaches are reducing their quality of life, but doctors say taking these steps can help.

Wegovy® is indicated for chronic weight management in adults and adolescents (12+) with obesity or overweight and at least ...

Investing.com -- 在宣布向欧洲药品管理局提交高剂量肥胖治疗药物Wegovy的批准申请后，诺和诺德公司 (NYSE: NVO )股价上涨1%。

A New Zealand bariatric surgeon cautions that Wegovy, a new weight-loss drug, isn't a magic bullet for obesity. While it can trigger initial weight loss, long-term success hinges on lifestyle changes ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Denmark's Novo Nordisk said on Tuesday it had submitted a new, higher dose of its obesity treatment Wegovy to the European ...

纽约 - WW International, Inc.（即WeightWatchers）周二宣布与诺和诺德公司扩大合作，将在2025年7月以299美元的优惠价格为WeightWatchers诊所会员提供FDA批准的Wegovy（司美格鲁肽）注射剂，相当于节省200美元。根据 InvestingPro ...

U.S. telehealth platform looks to take advantage of Ozempic patent expiring in January, while four manufacturers filed for ...

The recent approval of weight-loss drug Wegovy in New Zealand has been hyped as a breakthrough in the country’s fight against ...

The first study to put two GLP-1 weight loss drugs head-to-head found Zepbound helped people lose more weight than Wegovy.